Postoperative adjuvant management in hepatocellular carcinoma: A review of therapeutic efficacy and prognostic outcomes

Figure 2 Hepatocellular carcinoma treatment options[30]. This schematic illustrates key clinical considerations influencing treatment selection and their relative prioritization among physicians. The left panel depicts decision factors (represented as spheres), with connecting lines indicating individual practitioners’ (P1, P2, ...Pn) priority sequences for hepatocellular carcinoma management. The bottom legend (n^X) denotes the exponential growth of possible therapeutic combinations. The right panel demonstrates how final treatment plans emerge from integrated evaluations of clinical guidelines, patient-specific parameters, local resource availability, and health literacy considerations. Citation: Muñoz-Martínez S, Iserte G, Sanduzzi-Zamparelli M, Llarch N, Reig M. Current pharmacological treatment of hepatocellular carcinoma. Curr Opin Pharmacol 2021; 60: 141-148. Copyright© The Authors 2025. Published by Elsevier Ltd. (https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&contentID=S1471489221001028&orderBeanReset=true).